These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 1649971)

  • 1. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
    N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 3. Foscarnet effective in acyclovir-resistant herpes.
    Am Pharm; 1991 Nov; NS31(11):12. PubMed ID: 1836936
    [No Abstract]   [Full Text] [Related]  

  • 4. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
    Safrin S; Assaykeen T; Follansbee S; Mills J
    J Infect Dis; 1990 Jun; 161(6):1078-84. PubMed ID: 2161035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
    Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
    Sall RK; Kauffman CL; Levy CS
    Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
    Iino T; Gondo H; Ohno Y; Minagawa H; Iwasaki H; Maruyama T; Nakashima H; Niho Y
    Bone Marrow Transplant; 1996 Dec; 18(6):1185-8. PubMed ID: 8971394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J
    Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
    Hardy WD
    Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic erosive, therapy-resistant perianal herpes (type II) with herpes proctitis in AIDS].
    Bratzke B; Orfanos CE; Stavermann T; Ehlers G
    Hautarzt; 1991 Feb; 42(2):96-100. PubMed ID: 1828066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous herpes simplex virus infections.
    Arbesfeld DM; Thomas I
    Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
    Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
    Marks GL; Nolan PE; Erlich KS; Ellis MN
    Rev Infect Dis; 1989; 11(3):474-6. PubMed ID: 2546244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group.
    Whitley R; Arvin A; Prober C; Burchett S; Corey L; Powell D; Plotkin S; Starr S; Alford C; Connor J
    N Engl J Med; 1991 Feb; 324(7):444-9. PubMed ID: 1988829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report.
    Alvarez-McLeod A; Havlik J; Drew KE
    Clin Infect Dis; 1999 Oct; 29(4):937-8. PubMed ID: 10589917
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Verdonck LF; Cornelissen JJ; Smit J; Lepoutre J; de Gast GC; Dekker AW; Rozenberg-Arska M
    Bone Marrow Transplant; 1993 Feb; 11(2):177-9. PubMed ID: 8382096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
    Baumann R; Wunderli W; Riess C; Vogt M
    Schweiz Med Wochenschr; 1993 Dec; 123(51-52):2394-400. PubMed ID: 8290931
    [No Abstract]   [Full Text] [Related]  

  • 19. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
    McGrath BJ; Newman CL
    Pharmacotherapy; 1994; 14(5):529-42. PubMed ID: 7997387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic herpes resistant to acyclovir in a patient with AIDS].
    About I; Capdeville J; Bernard P; Massip P
    Ann Dermatol Venereol; 1994; 121(11):810-3. PubMed ID: 7631991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.